Lipid nanoparticles for topical application of drugs for skin diseases
Authors:
- Sanjay DeySDSanjay Dey
- Supriya DattaSDSupriya Datta
- Sandipan DasguptaSDSandipan Dasgupta
- Bhaskar MazumderBMBhaskar Mazumder
- Yasvant V. PathakYPYasvant V. Pathak
- 1 January 2016
- book chapter
- Published by Elsevier
- p. 327-361
Abstract
No abstract availableThis publication has 151 references indexed in Scilit:
- Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigationInternational Journal of Pharmaceutics, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Lipid nanoparticles for improved topical application of drugs for skin diseases☆Advanced Drug Delivery Reviews, 2007
- Lipid vesicles for skin delivery of drugs: Reviewing three decades of researchInternational Journal of Pharmaceutics, 2007
- Adverse effects of topical glucocorticosteroidsJournal of the American Academy of Dermatology, 2006
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosageBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Importance of Sebaceous Glands in Cutaneous Penetration of an Antiandrogen: Target Effect of LiposomesJournal of Pharmaceutical Sciences, 1997
- Liposomes - a selective drug delivery system for the topical route of administration I. Lotion dosage formLife Sciences, 1980
- Mechanism of Percutaneous AbsorptionJournal of Investigative Dermatology, 1967